Patient-Centered Placement Matching of Alcohol-Dependent Patients Based on a Standardized Intake Assessment: Primary Outcomes of an Exploratory Randomized Controlled Trial.

Alcohol use disorders Allocation guidelines Comprehensive assessment Health services research Measurements in the Addictions for Triage and Evaluation Patient-centered care Placement matching

Journal

European addiction research
ISSN: 1421-9891
Titre abrégé: Eur Addict Res
Pays: Switzerland
ID NLM: 9502920

Informations de publication

Date de publication:
2020
Historique:
received: 13 03 2019
accepted: 13 01 2020
pubmed: 20 2 2020
medline: 21 10 2020
entrez: 20 2 2020
Statut: ppublish

Résumé

Placement matching guidelines are promising means to optimize patient-centered care and to match patients' treatment needs. Despite considerable research regarding placement matching approaches to optimize alcohol abuse treatment, findings are inconclusive. To investigate whether the use of patient-centered placement matching (PCPM) guidelines is more effective in reducing heavy drinking and costs 6 months after discharge from an inpatient alcohol withdrawal treatment compared to usual referral to aftercare. Secondary aims were to investigate whether age, gender, trial site or level of care (LOC) are moderators of efficacy and whether patients who were actually referred to the recommended LOC had better treatment outcomes compared to patients who were treated under- or overmatched. Design. Exploratory randomized controlled trial with measurements during withdrawal treatment and 6 months after initial assessment. Four German psychiatric clinics offering a 7-21 day inpatient qualified withdrawal program for patients suffering from alcohol dependence. From 1,927 patients who had a primary diagnosis of alcohol dependence and did not have organized aftercare when entering withdrawal treatment, 299 were invited to participate. Of those, 250 were randomized to the intervention group (IG, n = 123) or the control group (CG, n = 127). The PCPM were applied to patients of the IG by feeding back a recommendation to a LOC for aftercare that was calculated from the Measurements in the Addictions for Triage and Evaluation (MATE) and discussed with the staff of the treatment unit. Patients of the CG received a general feedback regarding their MATE interview on request. The MATE, the Client Socio-Demographic and Service Receipt Inventory--European Version and the MATE-Outcomes were administered. Data were analyzed using generalized linear models. In the intention-to-treat analysis, there were no significant differences between IG and CG regarding days of heavy drinking (incident risk ratio [IRR] 1.09; p = 0.640), direct (IRR 1.06; p = 0.779), indirect (IRR 0.77; p = 0.392) and total costs (IRR 0.89; p = 0.496). Furthermore, none of the investigated moderator variables affected statistically significant drinking or cost-related primary outcomes. Regardless of group allocation, patients who received matched aftercare reported significantly fewer days of heavy drinking than undermatched patients (IRR 2.09; p = 0.004). For patients who were overmatched, direct costs were significantly higher (IRR 1.79; p = 0.024), but with no additional effects on alcohol consumption compared to matched patients. While the use of PCPM failed to affect the actual referral to aftercare, our findings suggest that treating patients on the recommended LOC may have the potential to reduce days of heavy drinking compared to undertreatment and costs compared to overtreatment.

Sections du résumé

BACKGROUND BACKGROUND
Placement matching guidelines are promising means to optimize patient-centered care and to match patients' treatment needs. Despite considerable research regarding placement matching approaches to optimize alcohol abuse treatment, findings are inconclusive.
OBJECTIVES OBJECTIVE
To investigate whether the use of patient-centered placement matching (PCPM) guidelines is more effective in reducing heavy drinking and costs 6 months after discharge from an inpatient alcohol withdrawal treatment compared to usual referral to aftercare. Secondary aims were to investigate whether age, gender, trial site or level of care (LOC) are moderators of efficacy and whether patients who were actually referred to the recommended LOC had better treatment outcomes compared to patients who were treated under- or overmatched.
METHODS METHODS
Design. Exploratory randomized controlled trial with measurements during withdrawal treatment and 6 months after initial assessment.
SETTING METHODS
Four German psychiatric clinics offering a 7-21 day inpatient qualified withdrawal program for patients suffering from alcohol dependence.
PARTICIPANTS METHODS
From 1,927 patients who had a primary diagnosis of alcohol dependence and did not have organized aftercare when entering withdrawal treatment, 299 were invited to participate. Of those, 250 were randomized to the intervention group (IG, n = 123) or the control group (CG, n = 127).
INTERVENTION METHODS
The PCPM were applied to patients of the IG by feeding back a recommendation to a LOC for aftercare that was calculated from the Measurements in the Addictions for Triage and Evaluation (MATE) and discussed with the staff of the treatment unit. Patients of the CG received a general feedback regarding their MATE interview on request.
MEASUREMENTS METHODS
The MATE, the Client Socio-Demographic and Service Receipt Inventory--European Version and the MATE-Outcomes were administered. Data were analyzed using generalized linear models.
RESULTS RESULTS
In the intention-to-treat analysis, there were no significant differences between IG and CG regarding days of heavy drinking (incident risk ratio [IRR] 1.09; p = 0.640), direct (IRR 1.06; p = 0.779), indirect (IRR 0.77; p = 0.392) and total costs (IRR 0.89; p = 0.496). Furthermore, none of the investigated moderator variables affected statistically significant drinking or cost-related primary outcomes. Regardless of group allocation, patients who received matched aftercare reported significantly fewer days of heavy drinking than undermatched patients (IRR 2.09; p = 0.004). For patients who were overmatched, direct costs were significantly higher (IRR 1.79; p = 0.024), but with no additional effects on alcohol consumption compared to matched patients.
CONCLUSIONS CONCLUSIONS
While the use of PCPM failed to affect the actual referral to aftercare, our findings suggest that treating patients on the recommended LOC may have the potential to reduce days of heavy drinking compared to undertreatment and costs compared to overtreatment.

Identifiants

pubmed: 32074597
pii: 000505913
doi: 10.1159/000505913
doi:

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

109-121

Informations de copyright

© 2020 S. Karger AG, Basel.

Auteurs

Angela Buchholz (A)

Department of Medical Psychology, Centre for Psychosocial Medicine, University Medical Centre, Hamburg, Germany, a.buchholz@uke.de.

Judith Dams (J)

Department of Health Economics and Health Services Research, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

Anke Rosahl (A)

Department of Medical Psychology, Centre for Psychosocial Medicine, University Medical Centre, Hamburg, Germany.

Jochen Hempleman (J)

LWL-Hospital Muenster, Outpatient Department for Addiction, Münster, Germany.

Hans-Helmut König (HH)

Department of Health Economics and Health Services Research, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

Alexander Konnopka (A)

Department of Health Economics and Health Services Research, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

Ludwig Kraus (L)

IFT Institut für Therapieforschung, Munich, Germany.
Department for Public Health Sciences, Stockholm University, Stockholm, Sweden.
Institute of Psychology, ELTE Eötvös Loránd University, Budapest, Hungary.

Levente Kriston (L)

Department of Medical Psychology, Centre for Psychosocial Medicine, University Medical Centre, Hamburg, Germany.

Daniela Piontek (D)

IFT Institut für Therapieforschung, Munich, Germany.

Jens Reimer (J)

Centre for Interdisciplinary Addiction Research, University of Hamburg, Hamburg, Germany.
Centre for Psychosocial Medicine, Health North, Bremen, Germany.

Jeanette Röhrig (J)

Department for Clinical Psychology, Municipal Clinical Center of Stuttgart, Stuttgart, Germany.

Norbert Scherbaum (N)

Department of Addictive Behavior and Addiction Medicine, LVR-Hospital Essen, Medical Faculty, University of Duisburg-Essen, Essen, Germany.

Anna Silkens (A)

Department of Addictive Behavior and Addiction Medicine, LVR-Hospital Essen, Medical Faculty, University of Duisburg-Essen, Essen, Germany.

Michael Berner (M)

Municipal Clinical Center of Karlsruhe, Karlsruhe, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH